Lantheus Holdings, Inc. Write off of Deferred Debt Issuance Cost
Lantheus Holdings, Inc. (LNTH) reported Write off of Deferred Debt Issuance Cost of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2018-02-26
- Lantheus Holdings, Inc. write off of deferred debt issuance cost for the quarter ending 2014-12-31 was $73.00K.
- Lantheus Holdings, Inc. write off of deferred debt issuance cost for fiscal 2017 was $0.00.
- Lantheus Holdings, Inc. write off of deferred debt issuance cost for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Lantheus Holdings, Inc. write off of deferred debt issuance cost for fiscal 2015 was $236.00K, a 90.13% decline from fiscal 2014.
- Lantheus Holdings, Inc. write off of deferred debt issuance cost for fiscal 2014 was $2.39M, a 300.00% increase from fiscal 2013.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-26 | ||
| 2016-12-31 | $0.00 10-K · filed 2018-02-26 | ||
| 2015-12-31 | $236.00K 10-K · filed 2018-02-26 | ||
| 2014-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $2.39M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $2.32M 10-Q · filed 2015-11-04 | ||
| 2013-12-31 | $598.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |